Haisco Pharmaceutical Group Co., Ltd.

This study aims to test the long-term safety and effectiveness of an experimental dry powder inhaler called HSK39004 for people with moderate-to-severe COPD. About 300 participants aged 40-80 will use the inhaler twice daily for a full year. The main goal is to see how well the t…

This study is testing whether a new oral medication called HSK44459 can safely reduce the severity of plaque psoriasis. About 150 adults with moderate to severe psoriasis will take either the drug or a placebo pill for 16 weeks. Researchers will measure how much the participants'…

This study will compare a new diabetes medication called cofrogliptin (taken once every two weeks) with an existing medication called acarbose (taken three times daily) in 200 people with type 2 diabetes who haven't tried medication before. Researchers want to see which drug work…

This study aims to test if an investigational drug called HSK47388 is effective and safe for treating moderate to severe plaque psoriasis. It will involve about 220 adults with significant skin coverage and compare the drug against a placebo over 16 weeks. The main goal is to see…